Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Analysis of the Prognostic Role of Epigenetic Biomarkers in Relation to the Motor Decline in Parkinson's Disease
Authors not listed
Istituto Nazionale di Ricovero e Cura per Anziani · 2024
Abstract
BioGenParkinson is an observational, prospective cohort study evaluating biomarkers of Parkinson's Disease (PD) progression in community-dwelling subjects aged 65 years or more, consecutively referring to INRCA outpatient clinic of the Neurology Unit. Selected patients will undergo clinical and laboratory evaluations at the baseline, and will be followed up after 6 and 12 months. The biological evaluation will include the determination of i) routine biological parameters ii) advanced biomarkers such as epigenetic analysis of DNA methylation, genetic analysis on multiple loci associated with PD progression and specific proteins associated with motor and non-motor decline. After obtaining all data, multiple statistical analysis will be performed to evaluate the most accurate prognostic biomarkers of PD progression at this stage of disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-28 MST
Cite this
APA
Anonymous. (2024). Analysis of the Prognostic Role of Epigenetic Biomarkers in Relation to the Motor Decline in Parkinson's Disease. <em>Istituto Nazionale di Ricovero e Cura per Anziani</em>. https://clinicaltrials.gov/study/NCT05384522
Vancouver
Anonymous. Analysis of the Prognostic Role of Epigenetic Biomarkers in Relation to the Motor Decline in Parkinson's Disease. Istituto Nazionale di Ricovero e Cura per Anziani. 2024.
BibTeX
@misc{anon2024Analys,
title = {Analysis of the Prognostic Role of Epigenetic Biomarkers in Relation to the Motor Decline in Parkinson's Disease},
author = {Anonymous},
journal = {Istituto Nazionale di Ricovero e Cura per Anziani},
year = {2024},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Internal Medicine 2022
Citation only
Epigenetic aging: Biological age prediction and informing a mechanistic theory of aging
TruDiagnostic 2021
Open access · US-GOV
Investigation of AC-11® Supplementation in Reversing Epigenetic Markers of Biological Aging Including Those Related to Telomere Length
Nature Reviews Neurology 2025
Preprint · CC-BY
Epigenetic clocks and DNA methylation biomarkers of brain health and disease
Scientific Reports 2023
Open access · CC-BY
DNA methylation variations and epigenetic aging in telomere biology disorders
Genes 2014
Open access · CC-BY
DNA Methylation Biomarkers: Cancer and Beyond
Danish Dementia Research Centre 2022
Open access · US-GOV